ID   DNJA3_MOUSE             Reviewed;         480 AA.
AC   Q99M87; Q8BSM0; Q99L09; Q99P71; Q99P76; Q9CT11; Q9DBJ7; Q9DC44;
DT   16-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-JAN-2026, entry version 188.
DE   RecName: Full=DnaJ homolog subfamily A member 3, mitochondrial;
DE   AltName: Full=DnaJ protein Tid-1;
DE            Short=mTid-1;
DE   AltName: Full=Tumorous imaginal discs protein Tid56 homolog;
DE   Flags: Precursor;
GN   Name=Dnaja3; Synonyms=Tid1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND INTERACTION WITH
RP   RASA1.
RC   STRAIN=C57BL/6 X CBA;
RX   PubMed=11116152; DOI=10.1074/jbc.m009267200;
RA   Trentin G.A., Yin X., Tahir S., Lhotak S., Farhang-Fallah J., Li Y.,
RA   Rozakis-Adcock M.;
RT   "A mouse homologue of the Drosophila tumor suppressor l(2)tid gene defines
RT   a novel Ras GTPase-activating protein (RasGAP)-binding protein.";
RL   J. Biol. Chem. 276:13087-13095(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Embryo, Forelimb, and Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION IN NEUROMUSCULAR JUNCTION DEVELOPMENT, INTERACTION WITH MUSK, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19038220; DOI=10.1016/j.neuron.2008.09.025;
RA   Linnoila J., Wang Y., Yao Y., Wang Z.Z.;
RT   "A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates
RT   agrin signaling at the neuromuscular junction.";
RL   Neuron 60:625-641(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, and Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-134, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23576753; DOI=10.1073/pnas.1302961110;
RA   Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J., Li B.,
RA   Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.;
RT   "Label-free quantitative proteomics of the lysine acetylome in mitochondria
RT   identifies substrates of SIRT3 in metabolic pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013).
CC   -!- FUNCTION: Modulates apoptotic signal transduction or effector
CC       structures within the mitochondrial matrix. Affect cytochrome C release
CC       from the mitochondria and caspase 3 activation, but not caspase 8
CC       activation. Isoform 1 increases apoptosis triggered by both TNF and the
CC       DNA-damaging agent mytomycin C; in sharp contrast, isoform 2 suppresses
CC       apoptosis. Can modulate IFN-gamma-mediated transcriptional activity (By
CC       similarity). Isoform 2 may play a role in neuromuscular junction
CC       development as an effector of the MUSK signaling pathway. {ECO:0000250,
CC       ECO:0000269|PubMed:19038220}.
CC   -!- SUBUNIT: Interacts with JAK2, HSPA9B and IFN-gammaR2 chain. Interacts
CC       with Ras GTPase-activating protein 1 (RASA1). Isoform 2 interacts with
CC       MUSK (via the cytoplasmic domain). {ECO:0000269|PubMed:11116152,
CC       ECO:0000269|PubMed:19038220}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:19038220}. Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:19038220}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:19038220}. Note=Recruited to the postsynaptic cell
CC       membrane of the neuromuscular junction through interaction with MUSK.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Tid-1L, TID1L;
CC         IsoId=Q99M87-1; Sequence=Displayed;
CC       Name=2; Synonyms=Tid-1S, TID1S;
CC         IsoId=Q99M87-2; Sequence=VSP_007427, VSP_007428;
CC       Name=3;
CC         IsoId=Q99M87-3; Sequence=VSP_007440;
CC   -!- DOMAIN: Modulation of apoptosis, i.e. proapoptotic activity of isoform
CC       1 and antiapoptotic activity of isoform 2, is J domain-dependent (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Tyrosine phosphorylated.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY009320; AAG37303.1; -; mRNA.
DR   EMBL; AF325535; AAK11222.1; -; mRNA.
DR   EMBL; AF326358; AAK11223.1; -; mRNA.
DR   EMBL; AK004575; BAB23384.1; -; mRNA.
DR   EMBL; AK004910; BAB23661.1; -; mRNA.
DR   EMBL; AK011535; BAB27682.2; -; mRNA.
DR   EMBL; AK031250; BAC27321.1; -; mRNA.
DR   EMBL; BC003920; AAH03920.1; -; mRNA.
DR   EMBL; BC027240; AAH27240.1; -; mRNA.
DR   CCDS; CCDS27922.1; -. [Q99M87-1]
DR   CCDS; CCDS49748.1; -. [Q99M87-2]
DR   RefSeq; NP_001128584.1; NM_001135112.1. [Q99M87-2]
DR   RefSeq; NP_076135.3; NM_023646.4. [Q99M87-1]
DR   AlphaFoldDB; Q99M87; -.
DR   SMR; Q99M87; -.
DR   BioGRID; 219986; 21.
DR   FunCoup; Q99M87; 2659.
DR   IntAct; Q99M87; 6.
DR   MINT; Q99M87; -.
DR   STRING; 10090.ENSMUSP00000053842; -.
DR   GlyGen; Q99M87; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q99M87; -.
DR   PhosphoSitePlus; Q99M87; -.
DR   SwissPalm; Q99M87; -.
DR   jPOST; Q99M87; -.
DR   PaxDb; 10090-ENSMUSP00000053842; -.
DR   PeptideAtlas; Q99M87; -.
DR   ProteomicsDB; 277475; -. [Q99M87-1]
DR   ProteomicsDB; 277476; -. [Q99M87-2]
DR   ProteomicsDB; 277477; -. [Q99M87-3]
DR   Pumba; Q99M87; -.
DR   Antibodypedia; 24319; 270 antibodies from 33 providers.
DR   DNASU; 83945; -.
DR   Ensembl; ENSMUST00000060067.12; ENSMUSP00000053842.6; ENSMUSG00000004069.18. [Q99M87-1]
DR   Ensembl; ENSMUST00000115854.4; ENSMUSP00000111520.4; ENSMUSG00000004069.18. [Q99M87-2]
DR   Ensembl; ENSMUST00000229529.2; ENSMUSP00000155588.2; ENSMUSG00000004069.18. [Q99M87-3]
DR   GeneID; 83945; -.
DR   KEGG; mmu:83945; -.
DR   UCSC; uc007yac.2; mouse. [Q99M87-1]
DR   UCSC; uc012aat.1; mouse. [Q99M87-3]
DR   AGR; MGI:1933786; -.
DR   CTD; 9093; -.
DR   MGI; MGI:1933786; Dnaja3.
DR   VEuPathDB; HostDB:ENSMUSG00000004069; -.
DR   eggNOG; KOG0715; Eukaryota.
DR   GeneTree; ENSGT00940000155280; -.
DR   HOGENOM; CLU_017633_0_5_1; -.
DR   InParanoid; Q99M87; -.
DR   OMA; MATDYYA; -.
DR   OrthoDB; 10256793at2759; -.
DR   PhylomeDB; Q99M87; -.
DR   BioGRID-ORCS; 83945; 23 hits in 78 CRISPR screens.
DR   CD-CODE; CE726F99; Postsynaptic density.
DR   PRO; PR:Q99M87; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; Q99M87; protein.
DR   Bgee; ENSMUSG00000004069; Expressed in interventricular septum and 258 other cell types or tissues.
DR   ExpressionAtlas; Q99M87; baseline and differential.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; ISO:GO_Central.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; ISO:GO_Central.
DR   GO; GO:0042645; C:mitochondrial nucleoid; ISO:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IEA:GOC.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:GO_Central.
DR   GO; GO:0030695; F:GTPase regulator activity; IDA:MGI.
DR   GO; GO:0030544; F:Hsp70 protein binding; ISO:GO_Central.
DR   GO; GO:0106137; F:IkappaB kinase complex binding; ISO:GO_Central.
DR   GO; GO:0051059; F:NF-kappaB binding; ISO:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; ISO:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:GO_Central.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:GO_Central.
DR   GO; GO:0005133; F:type II interferon receptor binding; ISO:GO_Central.
DR   GO; GO:0051082; F:unfolded protein binding; IPI:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006924; P:activation-induced cell death of T cells; IMP:MGI.
DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.
DR   GO; GO:0090398; P:cellular senescence; IDA:MGI.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IMP:MGI.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:GO_Central.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISO:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:GO_Central.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:GO_Central.
DR   GO; GO:0060336; P:negative regulation of type II interferon-mediated signaling pathway; ISO:GO_Central.
DR   GO; GO:0007528; P:neuromuscular junction development; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:GO_Central.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISO:GO_Central.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IMP:MGI.
DR   GO; GO:0006457; P:protein folding; ISO:GO_Central.
DR   GO; GO:0050821; P:protein stabilization; ISO:GO_Central.
DR   GO; GO:0009408; P:response to heat; IEA:InterPro.
DR   GO; GO:0034341; P:response to type II interferon; ISO:GO_Central.
DR   GO; GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; IMP:UniProtKB.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; IDA:MGI.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IMP:MGI.
DR   CDD; cd06257; DnaJ; 1.
DR   CDD; cd10747; DnaJ_C; 1.
DR   CDD; cd10719; DnaJ_zf; 1.
DR   FunFam; 2.60.260.20:FF:000005; Chaperone protein dnaJ 1, mitochondrial; 1.
DR   FunFam; 2.10.230.10:FF:000003; dnaJ homolog subfamily A member 3, mitochondrial; 1.
DR   FunFam; 1.10.287.110:FF:000025; dnaJ homolog subfamily A member 3, mitochondrial isoform X2; 1.
DR   Gene3D; 1.10.287.110; DnaJ domain; 1.
DR   Gene3D; 2.10.230.10; Heat shock protein DnaJ, cysteine-rich domain; 1.
DR   Gene3D; 2.60.260.20; Urease metallochaperone UreE, N-terminal domain; 2.
DR   HAMAP; MF_01152; DnaJ; 1.
DR   InterPro; IPR051938; Apopto_cytoskel_mod.
DR   InterPro; IPR012724; DnaJ.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR001305; HSP_DnaJ_Cys-rich_dom.
DR   InterPro; IPR036410; HSP_DnaJ_Cys-rich_dom_sf.
DR   InterPro; IPR036869; J_dom_sf.
DR   PANTHER; PTHR44145; DNAJ HOMOLOG SUBFAMILY A MEMBER 3, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR44145:SF3; DNAJ HOMOLOG SUBFAMILY A MEMBER 3, MITOCHONDRIAL; 1.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   Pfam; PF00684; DnaJ_CXXCXGXG; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; Chaperone J-domain; 1.
DR   SUPFAM; SSF57938; DnaJ/Hsp40 cysteine-rich domain; 1.
DR   SUPFAM; SSF49493; HSP40/DnaJ peptide-binding domain; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS51188; ZF_CR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; Cell membrane; Chaperone;
KW   Cytoplasm; Membrane; Metal-binding; Methylation; Mitochondrion;
KW   Phosphoprotein; Postsynaptic cell membrane; Reference proteome; Repeat;
KW   Synapse; Transit peptide; Zinc; Zinc-finger.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..480
FT                   /note="DnaJ homolog subfamily A member 3, mitochondrial"
FT                   /id="PRO_0000007257"
FT   DOMAIN          93..158
FT                   /note="J"
FT   REPEAT          236..243
FT                   /note="CXXCXGXG motif"
FT   REPEAT          253..260
FT                   /note="CXXCXGXG motif"
FT   REPEAT          275..282
FT                   /note="CXXCXGXG motif"
FT   REPEAT          289..296
FT                   /note="CXXCXGXG motif"
FT   ZN_FING         223..301
FT                   /note="CR-type"
FT   REGION          437..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        439..456
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         236
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         239
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         253
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         256
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         275
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         278
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         289
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         292
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         58
FT                   /note="Omega-N-methylarginine; by CARM1"
FT                   /evidence="ECO:0000250|UniProtKB:Q96EY1"
FT   MOD_RES         134
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23576753"
FT   MOD_RES         238
FT                   /note="Omega-N-methylarginine; by CARM1"
FT                   /evidence="ECO:0000250|UniProtKB:Q96EY1"
FT   MOD_RES         293
FT                   /note="Omega-N-methylarginine; by CARM1"
FT                   /evidence="ECO:0000250|UniProtKB:Q96EY1"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96EY1"
FT   VAR_SEQ         211..261
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11116152"
FT                   /id="VSP_007440"
FT   VAR_SEQ         448..453
FT                   /note="GRTMDS -> KRSTGN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11116152,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_007427"
FT   VAR_SEQ         454..480
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11116152,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_007428"
FT   CONFLICT        403
FT                   /note="D -> H (in Ref. 2; BAB23661)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        456
FT                   /note="G -> E (in Ref. 2; BAB23384)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   480 AA;  52443 MW;  30AA5557C18665A8 CRC64;
     MAAWCSPRWL RVAVGTPRLP AAAGRGVQQP QGGVVATSLC RKLCVSAFGL SMGAHGPRAL
     LTLRPGVRLT GTKSFPFVCT TSFHTSASLA KDDYYQILGV PRNASQKDIK KAYYQLAKKY
     HPDTNKDDPK AKEKFSQLAE AYEVLSDEVK RKQYDAYGSA GFDPGTSSSG QGYWRGGPSV
     DPEELFRKIF GEFSSSPFGD FQNVFDQPQE YIMELTFNQA AKGVNKEFTV NIMDTCERCD
     GKGNEPGTKV QHCHYCGGSG METINTGPFV MRSTCRRCGG RGSIITNPCV VCRGAGQAKQ
     KKRVTIPVPA GVEDGQTVRM PVGKREIFVT FRVQKSPVFR RDGADIHSDL FISIAQAILG
     GTAKAQGLYE TINVTIPAGI QTDQKIRLTG KGIPRINSYG YGDHYIHIKI RVPKRLSSRQ
     QNLILSYAED ETDVEGTVNG VTHTSTGGRT MDSSAGSKDR REAGEDNEGF LSKLKKIFTS
//
